2. Fisang С., Anding R., Lats S., Laude N. Dtsch Arztebl Int. 2015;112:83–91.

3. Gambaro G., Reis-Santos, J.M., Rao N. Nephrolithiasis: why doesn’t our ‘learning’ progress? Eur. Urol. 2004;45:547–556.

4. Meneses J.A., Lucas F.M., Castro J.P., Monteiro R.B. The impact of metaphylaxis of kidney stone disease in the renal function at long term in active kidney stone formers patients. Urol Res. 2012;40(3):225–229.

5. Chandhoke P.S. When is medical prophylaxis cost-effective for recurrent calcium stones? J Urol. 2002;168:937–940. Doi: 10.1097/01.ju.0000024921.93877.f1

6. Ferucci P.G., Sankey N., Chandhoke P.S. Am Surg. 2002;68(2):201–203.

7. Siener R., Glatz S., Nicolay C., Hesse A. Prospectiv study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients. Eur. Urol. 2009;S8:205.

8. Strohmaier W.L. 2012 Economics of stone disease/treatment. Arab J Urol. 2012;10:273–278.

9. Eisner B.H., Sheth S., Dretler S.P., Herrick B., Pais V.M. Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers. Urology. 2012;80:776–779.

10. Primiano A. et al. FT-IR analysis of urinary stones: a helpful tool for clinician comparison with the chemical spot test. Dis. Markers. 2014;17:61–65.

11. Kristensen C., Parks J.H., Lindheimer M., Coe F.L. Reduced glomerular filtration rate and hypercalciuria in primary struvite nephrolithiasis. Kidney Int. 1987;32:749–753.

12. Evan A.P. et al. Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones. Anat. Rec. (Hoboken) 2014;297,:731–748.

13. Levine J.A., Neitlich J., Verga M., Dalrymple N., Smith R.C. Ureteral calculi in patient with flank pain: correlation of plain radiography with unenhanced helical CT. Radiology. 1997;204(1):27–31.

14. Demirel A., Suma S. The efficacy of non-contrast helical cjmputed tomography in the prediction of urinary stone composition in vivo. J Int Med Res. 2003;31(1):1–5.

15. Ascenti G. et al. Stone-targeted dual-energy CT: a new diagnostic approach to urinary calculosis. AJR Am. J. Roentgenol. 2010;195:953–958.

16. Brown C.M., Ackermann D.K., Purich D.L. EQUIL93: a tool for experimental and clinical urolithiasis. Urol. Res. 1994;22:119–126.

17. Robertson W.G. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall’s plugs and calcium oxalate crystalluria in a computer model of renal function. Urolithiasis. 2015;43(Suppl. 1):93–107.

18. Asplin J.R., Mandel N.S., Coe F.L. Evidence of calcium phosphate supersaturation in the loop of Henle. Am. J. Physiol. 1996;270:F604–F613.

19. Kok D.J., Khan S.R. Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney International. 1994;46(3):847–854.

20. Robertson W.G. Kidney models of calcium oxalate stone formation. Nephron–Physiology. 2004;98(2):р21–p30.

21. Finlayson B., Reid F. The expectation of free and fixed particles in urinary stone disease. Investigative Urology, 1978;15(6):442–448.

22. Lotan Y., Jimenez I.B., Lenoir-Wijnkoop I., et al. Primary prevention of nephrolithiasis is cost-effective for a national healthcare system.BJU Int. 2012.

23. Bezrukov E.A., Saenko V.S., Kantenirov F.H., Kantemirov D.F., Alyaev Yu.G.Effect of hardness of mineral water on incidence of urinary stone disease and stone chemical composition in inhabitants of Kumertau and Meleuz. Medicinskyi vestnik Bashkortostana. 2015;3:83–87. Russian (Безруков Е.А., Саенко В.С., Кантемиров Ф.Х., Кантемиров Д.Ф., Аляев Ю.Г. Влияние жесткости питьевой воды на возникновение мочекаменной болезни и химический состав камней у жителей городов Кумертау и Мелеуз. Медицинский вестник Башкортостана. 2015;3:83–87).

24. Konstantinova O.V., Yanenko E.K., Chudnovskaya M.V., Kul’ga L.G. Influence of antibacterial drugs on urine pH in patients with calcium oxalate stones. Tezisy dokl. “Ecologic aspects of urologic pathology”. Materialy IV konferencii urologov Kazahstana. Alma-Ata, 1992. с. 24–25. Russian (Константинова О.В., Яненко Э.К., Чудновская М.В., Кульга Л.Г. Влияние антибактериальных препаратов на рН мочи больных с кальций-оксалатной формой уролитиаза. Тезисы докл. «Экологические аспекты урологической патологии». Материалы IV конференции урологов Казахстана. Алма-Ата, 1992. C. 24–25).

25. Golovanov S.A., Sivkov A.V., Polikarpova A.M., Drojjeva S.A., Andryukhin M.I., Prosyannikov M.Yu. Eksperimental’naya i klinicheskaya urologiia. 2018;1:84–91. Russian (Голованов С.А., Сивков А.В., Поликарпова А.М., Дрожжева В.В., Андрюхин М.И., Просянников М.Ю.Экспериментальная и клиническая урология. 2018;1:84–91).

26. Asplin J.R. Uric acid stones. Semin Nephrol. 1996;16:412–24.

27. Taylor E.N., Stampfer M.J., Curhan G.C. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455–462.

28. Powell C.R., Stoller M.L., Schwartz B.F., Kane C., Gentle D.L., Bruce J.E.,et al. Impact of body weight on urinary electrolytes in urinary stone formers. Urology. 2000;55:825–830.

29. Del Valle E.E., Negri A.L., Spivacow F.R., Rosende G., Forrester M., Pinduli I.Metabolic diagnosis in Stone formers in relation to body mass index. Urol Res. 2012;40:47–52.

30. Taylor E.N., Curhan G.C. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48:905–915.

31. Daudon M., Lacour B., Jungers P. Influence of body size on urinary stone composition in men and women. Urol Res. 2006;34:193–199.

32. Daudon M, Lacour B., Jungers P. Influence of body size on urinary stone composition in men and women. Urol Res 2006;34:193–199.

33. Maalouf N.M., Sakhaee K., Parks J.H., Coe F.L., Adams-Huet B., Pak C.Y.C.Association of urinary pH with body weight in nephrolithiasis. Kidney Int. 2004;65:1422–1425.

34. Asplin J.R., Coe F.L. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007;177:565–669.

35. Robertson W.G., Heyburn P.J., Peacock M., Hanes F.A., Swaminathan R.The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci (Lond). 1979;57:285–288.

36. Nelson W.K., Houghton S.G., Milliner D.S., Lieske J.C., Sarr M.G. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2005;1:481–485.

37. Dzeranov N.K., Konstantionova O.V., Cherepanova E.V., Nikonova L.M.,Lavrinova L.N., Chernyi A.I., Ivanov S.S. Use of mineral water “Zabruchanskaya Naftusya” in complex treatment of patients with urinary stone disease and chronic pyelonephritis. Tezisy dokladov II Vserossiiskaya nauchno-prakticheskaya konferenciya s megdunarodnym uchastiem “Rational pharmacotherapy in urology, 2008». М., 2008 p. 7–8. Russian (Дзеранов Н.К., Константинова О.В., Черепанова Е.В.,Никонова Л.М., Лавринова Л.Н., Черный А.И., Иванов С.С. Применение минерально воды «Забручанская нафтуся» в комплексном лечении пациентов с мочекаменной болезню и хроническим пиелонефритом. Тезисы докладов II Всероссийская научно-практическая конференция с международным участием «Рациональная фармакотерапия в урологии, 2008». М.,2008. C. 7–8).

38. Konstantionova O.V., Katibov M.I., Yanenko E.K., Kalinichenko D.N., Getcaev T.K. Urinary enzyme values during use of mineral water “Naftusya” of Zabruchanskogo filed for complex treatment of urinary stone disease. Tezisy dokl. Sb. materialov ХХ Yubileynogo Rossiskogo natcional’nogo kongressa «Chelovek i lekarstvo». М., 15–19 April 2013, p. 359. Russian (Константинова О.В., Катибов М.И., Яненко Э.К., Калиниченко Д.Н., Гецаев Т.К. Показатели ферментурии при рименении вода «Нафтуся» Забручанского месторожденич в комплексном лечении больных с мочевыми камнями. Тезисы докл. Сб. материалов ХХ Юбилейного Российского национального конгресса «Человек и лекарство». М., 15–19 апреля2013. C. 359).

39. Konstantionova O.V., Dutov V.V., Katibov M.I., Trapeznikova M.F., Yanenko E.K., Merinov D.S. Experience of using mineral water «Naftusya» of Zabruchanskaya field in the treatment of patients with urinary stones. Urologiia. 2013;6:9–13. Russian (Константинова О.В., Дутов В.В., Катибов М.И., Трапезникова М.Ф., Яненко Э.К., Меринов Д.С. Опыт применения минеральной воды «Нафтуся» Забручансекого местолрождения в лечении пациентов с мочевыми камнями. Урология. 2013;6:9–13).

40. Alyaev Yu.G., Amosov A.V., Saenko V.S., Shestiperov P.A., Mel’nikov D.V. Mineral water “Fiuggi” for recurrence prevention of urinary stone disease. Vrachebnoe soslovie. 2008;2:36–40. Russian (Аляев Ю.Г., Амосов А.В., Саенко В.С., Шестиперов П.А., Мельников Д.В. Вода «Фьюджи» в метафилактике мочекаменной болезни. Врачебное сословие. 2008;2:36–40).

41. Ardashnikova S.N., Ardacshnikov M.S., Belen’kyi L.S., Vishnevskyi et al. General balneology. Medgiz, 1959 y. Russian (Ардашникова С.Н. Ардашников, М.С. Беленький, Л.С. Вишневский и д-р. Общая курортотерапия. Медгиз, 1959).

42. Antonelli I.B. Jimйnez H., Gharbi R,. Herring A., Beaver A., Dennis D. Von Merveldt, Carter S., Cohen A., Poindexter J., Moe O.W., Pearle M.S. The kidney stone and increased water intake trial in steel workers: results from a pilot study. Y. Lotan. J. Urolithiasis. Doi: 10.1007/s00240-016-0892-7.

43. Touhami M., Laroubi A., Elhabazi K., Loubna F., Zrara I., Eljahiri Y., Oussama A., Grases F.x, Chait A. Lemon juice has protective activity in a rat urolithiasis model. BMC Urology. 2007:18 https://doi.org/10.1186/1471-2490-7-18

44. Birowo P., Widyahening I.S. Effect of citrus-based products on urine profile: A systematic review and meta-analysis. Nur Rasyid. 2017;6:220. Doi: 10.12688/f1000research.10976.1.

45. Siddiquia W.A., Shahzada M., Shabbirb A., Ahmadc A. Evaluation of anti-urolithiatic and diuretic activities of watermelon (Citrullus lanatus) using in vivo and in vitro experiments. Biomedicine & Pharmacotherapy. 2018;97:1212–1221.

46. Grases F., Costa-Bauza A., Prieto R.M. May renal lithiasis be really prevented? New trends and therapeutic tools. Arch Esp Urol. 2017;70(1)91–102.